Nathan Hanan

机构：GlaxoSmithKline (United States), Simulation Technologies (United States), Smiths Detection (Canada), GlaxoSmithKline (Brazil), Kalamazoo College · ORCID：0000-0001-9528-6141

发表论文 21 篇 · 总被引 356 次 · h-index 7

代表论文

• Marijuana Use by Breastfeeding Mothers and Cannabinoid Concentrations in Breast Milk (2018 · PEDIATRICS · 被引 184)
• Modeling Nikkomycin Z Dosing and Pharmacology in Murine Pulmonary Coccidioidomycosis Preparatory to Phase 2 Clinical Trials (2014 · The Journal of Infectious Diseases · 被引 63)
• Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus (2022 · Journal of Translational Autoimmunity · 被引 38)
• A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation (2021 · Clinical Pharmacology & Therapeutics · 被引 19)
• Opportunities and Challenges of Disease Progression Modeling in Drug Development – An IQ Perspective (2023 · Clinical Pharmacology & Therapeutics · 被引 9)
• Longitudinal Meta‐Analysis of Historical Parkinson's Disease Trials to Inform Future Trial Design (2023 · Movement Disorders · 被引 8)